Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-FR Version v15-EN
Language French English
Date Updated 2024-04-18 2024-04-18
Drug Identification Number 00583413 00583413
Brand name TEVA-CEPHALEXIN TEVA-CEPHALEXIN
Common or Proper name TEVA-CEPHALEXIN 250MG TAB TEVA-CEPHALEXIN 250MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients CEPHALEXIN CEPHALEXIN
Strength(s) 250MG 250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code J01DB J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-11-01 2023-11-01
Estimated end date 2024-06-20 2024-06-20
Actual end date 2024-04-17 2024-04-17
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments